 |
||
|
|
||
BY DEBU TRIPATHY | DECEMBER 8, 2011
Dr. Debu Tripathy explains the updated results of the BOLERO-2 study, which looked at Afinitor (everolimus) and an aromatase inhibitor in metastatic breast cancer. How useful will this new drug be in metastatic breast cancer?
RELATED POSTS
COMMENTS (0) |
PRINT |
SUBSCRIBE
COMMENTS
There are no comments for this entry.